Levine Cancer Institute - Ballantyne is a clinical research site located in Charlotte, North Carolina, United States 28277.
Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.
Levine Cancer Institute - Ballantyne has participated in 3 clinical trials with 1 currently active.
Therapeutic areas: Urothelial Carcinoma, Prostate Cancer, Pancreatic Cancer.
Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer, Wake Forest University Health Sciences.
Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Levine Cancer Institute - Ballantyne has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Levine Cancer Institute - Ballantyne has 3 clinical trials on record, with 1 currently active. Their work covers Urothelial Carcinoma, Prostate Cancer, Pancreatic Cancer.
Levine Cancer Institute - Ballantyne has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.